SREBF1 and metabolic dysfunction-associated steatotic liver disease: For instance, antrodan alleviates NAFLD by modulating the AMPK-SREBP-1c-PPARγ pathway, while xanthohumol ameliorates hepatic steatosis by inhibiting the SCAP/SREBP complex [204].